A med spa should expect 4 to 8 times return on ad spend at the account level, and between roughly 4 and 20 times at the treatment-line level once a full 12 months of client revenue is counted. Neurotoxin, laser packages, and membership-linked facials produce the highest margin-adjusted return. Body contouring produces the highest first-visit return and one of the lowest 12-month returns. These are agency averages, not guarantees.
This post is the revenue side of the med spa treatment-line question. The ClinicAds med spa advertising benchmarks post already carries what each line costs to book, and the med spa marketing guide already covers which lines belong in the budget. Neither one divides the revenue by the cost. This post does that three ways: first-visit ROAS, 12-month cohort ROAS, and 12-month ROAS after contribution margin, because the three rankings disagree and the disagreement is what decides a mix.
- A properly tracked med spa account returns 4 to 8 times its monthly ad spend, but the treatment lines inside that account return anywhere from roughly 4x to more than 20x on a 12-month cohort basis. Agency averages, not guarantees.
- First-visit ROAS ranks body contouring first and medical facials last. Margin-adjusted 12-month ROAS reverses most of that order, because body contouring rarely repeats and facials convert to memberships.
- Contribution margin varies from roughly 40 percent on GLP-1 to roughly 70 percent on laser and energy devices, so two lines with identical revenue ROAS do not deliver identical profit.
- Two med spas running the same $5,000 month on different treatment mixes can end the year with near-identical contribution and a 40-client difference in their recurring base.
- Line-level cohort ROAS runs higher than the 4 to 8 times account band because the two figures use different windows: 12 months of client revenue against one month of spend, versus tracked same-month revenue against same-month spend.
What ROAS should a med spa expect from paid ads?
A med spa running a tracked paid program on $3,000 to $8,000 per month should expect 4 to 8 times return on ad spend measured in-period. Measured as a cohort, meaning all revenue a month of advertising produces over the following 12 months, the same program typically returns 12 to 25 times. Both numbers are correct. They answer different questions, and a med spa that mixes them will either overspend or underspend by a wide margin.
The number that varies most is neither of those. It is the spread between treatment lines inside one account. A ClinicAds med spa account concentrated in neurotoxin and membership facials and a med spa account concentrated in body contouring can post the same blended in-period ROAS while building completely different businesses. These are agency averages across active med spa accounts, not guarantees.
What ROAS does each med spa treatment line produce?
Med spa ROAS by treatment line ranges from roughly 4 times on medical facials at the first visit to more than 20 times on body contouring at the first visit, then compresses sharply once repeat cadence and contribution margin are applied. Neurotoxin, laser packages, and facials all gain on a 12-month view. Body contouring and dermal filler both lose ground, because neither one brings the client back inside the year at a meaningful rate.
The table below is the three-way cut ClinicAds uses when choosing which lines carry a budget. Acquisition cost is per seated appointment, meaning cost per booked appointment adjusted for a 78 to 88 percent show rate. Contribution margin is revenue after product, consumable, and provider cost, before overhead. These are agency averages, not guarantees.
| Treatment line | Cost per seated appointment | First-visit ROAS | 12-month cohort ROAS | Contribution margin | 12-month ROAS after margin |
|---|---|---|---|---|---|
| Neurotoxin (Botox, Dysport) | $34-54 | 6-10x | 18-25x | 55-60% | 10-14x |
| Dermal filler | $42-72 | 10-18x | 14-20x | 50-55% | 7-10x |
| Laser and energy devices | $48-84 | 6-12x | 18-30x | 65-75% | 13-21x |
| Medical facials and peels | $34-58 | 3-5x | 20-30x | 50-60% | 11-17x |
| Body contouring | $72-132 | 15-28x | 16-28x | 45-55% | 8-14x |
| GLP-1 weight management | $54-96 | 3.5-6x | 20-35x | 40-50% | 9-16x |
Why does first-visit ROAS rank treatments wrong?
First-visit ROAS rewards ticket size and ignores whether the client comes back, which inverts the ranking for a business whose economics are built on repeat visits. Body contouring returns 15 to 28 times at the first visit and barely improves across the following year, because the client who buys a contouring package rarely buys a second one. Medical facials return 3 to 5 times at the first visit and 20 to 30 times across 12 months, because 35 to 45 percent of those clients convert to a membership at $120 to $280 per month.
This is the single most common misread ClinicAds sees in med spa ad reporting. A platform dashboard reports conversion value at the point of purchase, so it shows the contouring campaign winning by a factor of five over the facial campaign in week two. The facial campaign passes it somewhere around month four and never gives the lead back. A spa that reallocates on the week-two view moves money away from the line that was building its recurring base.
- Body contouring: 15-28x first visit, 16-28x at 12 months, meaning almost no repeat contribution
- Medical facials: 3-5x first visit, 20-30x at 12 months, a 5 to 6 times gain from membership conversion
- Neurotoxin: 6-10x first visit, 18-25x at 12 months, driven by a 3 to 4 month repeat cadence and a 55 to 65 percent return rate
- GLP-1 weight management: 3.5-6x first month, 20-35x at 12 months on 5 to 7 months of average retention
How does treatment mix change a $5,000 month?
Treatment mix changes the shape of a $5,000 med spa month far more than channel choice does. Two spas spending the same money through the same platforms, one led by injectables and membership facials and one led by body contouring, produce first-visit revenue that differs by a factor of two and year-one contribution that differs by almost nothing. What separates them is how many clients they own at the end of the year.
Worked example on $5,000. Spa A allocates 60 percent to neurotoxin, 25 percent to membership facials, and 15 percent to filler, seating roughly 109 new clients and producing about $39,000 in first-visit revenue. Spa B allocates 55 percent to body contouring, 25 percent to laser, and 20 percent to neurotoxin, seating roughly 69 new clients and producing about $78,000 in first-visit revenue. Across 12 months Spa A reaches about $112,000 in cohort revenue and Spa B about $120,000. After contribution margin the two land within a few hundred dollars of each other, near $64,000 each. Spa A starts the following year with 109 clients, 27 of them on membership. Spa B starts it with 69 clients and almost no recurring base. These are agency averages, not guarantees.
- Same $5,000, same platforms: 109 new clients versus 69
- First-visit revenue: about $39,000 versus about $78,000
- 12-month cohort revenue: about $112,000 versus about $120,000
- 12-month contribution: roughly $64,000 in both cases
- Recurring base carried into year two: 27 members versus close to zero
Why is line-level ROAS higher than the 4 to 8 times band?
Line-level ROAS in this post is a 12-month cohort figure and the 4 to 8 times band ClinicAds quotes for med spa accounts is a same-month tracked figure, so the two use different numerators over different windows. The account band divides revenue attributed inside the reporting month by that month's spend. The cohort figures divide everything a month of advertising eventually produces by that same month's spend. A client acquired in March who returns in July and September contributes to the cohort number and not to the March report.
Two other effects widen the gap. Under-attribution removes 25 to 40 percent of resulting revenue from the in-period report, because clients call, walk in, or search the brand name before booking, and no compliant med spa tracking setup captures all of that. Cross-line purchasing adds revenue the campaign never claims, since a client acquired on a facial offer who later buys neurotoxin is usually recorded as organic. A med spa should plan its budget against the 4 to 8 times in-period band, which is the conservative and observable one, and choose its treatment mix against the cohort table.
Which ROAS number should a med spa manage to?
A med spa should set budget against in-period ROAS, judge treatment mix against margin-adjusted 12-month ROAS, and review both on a fixed schedule rather than reacting to either one weekly. In-period ROAS is the number that tells a spa whether it can afford next month. Margin-adjusted cohort ROAS is the number that tells it what to advertise. Managing to only the first produces a spa that survives every month and owns nothing.
The practical sequence ClinicAds runs on a med spa account follows a fixed order, and each step has a threshold rather than a judgment call.
- 1. Confirm cost per seated appointment sits inside the $28 to $80 booked band adjusted for show rate before reading any ROAS figure
- 2. Hold 60 to 70 percent of budget on lines whose margin-adjusted 12-month ROAS clears 10x
- 3. Cap first-visit-heavy lines such as body contouring at 25 to 30 percent of budget regardless of how strong the dashboard looks
- 4. Track trial-to-member conversion monthly; under 15 percent means fix retention before raising spend
- 5. Re-cut the cohort table every two quarters, since product cost and platform auction pricing both move
What is a good ROAS for a med spa?
4 to 8 times monthly ad spend measured in-period is the working band for a tracked med spa account on $3,000 to $8,000 per month. Measured across 12 months of client revenue, the same program typically returns 12 to 25 times. Agency averages, not guarantees.
Which med spa treatment has the highest ROAS?
It depends on the window. Body contouring is highest at the first visit at 15 to 28 times. Laser and energy devices are highest after 12 months and contribution margin at 13 to 21 times, with medical facials close behind at 11 to 17 times because of membership conversion.
Why does my ad platform report a different ROAS than my books?
Platform dashboards record value at the point of purchase and miss 25 to 40 percent of resulting revenue that arrives by phone, walk-in, or brand search. Compliant med spa tracking makes that gap smaller through server-side conversions, but it does not close it. Reconcile the platform figure against practice management revenue monthly.
Should a med spa advertise body contouring at all?
Yes, as a capped share rather than a lead line. Body contouring produces strong first-visit revenue and very little repeat, so ClinicAds typically holds it at 25 to 30 percent of budget and funds the recurring lines with the rest.
How long before med spa ROAS is readable?
In-period ROAS is readable at day 30 and stable by day 60. Cohort ROAS needs two full repeat cadences, which is roughly 6 to 8 months on injectables and 12 months on laser packages. Judging a treatment line before its second cadence measures ticket size rather than return.